Swedish Orphan Biovitrum AB (OSTO:SOBI)
kr 276.4 3 (1.1%) Market Cap: 93.94 Bil Enterprise Value: 112.63 Bil PE Ratio: 43.61 PB Ratio: 2.63 GF Score: 87/100

Q3 2023 Swedish Orphan Biovitrum AB (publ) Earnings Call Transcript

Oct 30, 2023 / 12:00PM GMT
Release Date Price: kr230 (+3.05%)
Operator

Ladies and gentlemen, welcome to the Q3 2023 Report Conference Call and Live Webcast. I am Sandra, the Chorus Call operator. (Operator Instructions) At this time, it's my pleasure to hand over to Guido Oelkers, CEO. Please go ahead, sir.

Guido Oelkers;publ;CEO;President
Swedish Orphan Biovitrum AB

()-&

Thank you so much, and hello, everyone. This is Guido Oelkers, CEO of Sobi. We are delighted to welcome you to the third quarter 2023 conference call for investors and analysts. And as you can tell from our previous announcement, we are pleased with our performance in 2023 so far. We posted this presentation to Sobi.com earlier today.

Please turn to Slide 2, where we're looking the statement as per usual. We would like to remind you of those provisions in line with normal procedures. Unless stated otherwise, we will be making comments that mostly relate to the third quarter performance in 2023 at constant currency rate and in million Swedish krona.

Please turn to Slide 3. Today, we will cover

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot